Employees: 1,998
Size Bayzed Health (2609.HK) is a Hong Kong Health Care company (Hospital/Nursing Management) with a market value of $375M, the 834th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.25 on 18 Nov 2026.
Performance Over six months the shares fell 58.1%, against -3.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — lowest of 19 in its peer set.
Growth Revenue fell 1.9% over the last twelve months (peer median +11.9%); the operating margin is 4.7% (peer median 10.7%).
Valuation It trades at 2.4× enterprise value to sales against a peer median of 2.6× (10th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.0 points below its cost of capital (5.5% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$1.26B | HK$1.21B | HK$1.29B | HK$1.18B | HK$933M |
| Revenue growth | — | -6% | +9% | +27% | — |
| Gross profit | HK$216M | HK$207M | HK$195M | HK$171M | HK$70.0M |
| EBITDA | HK$170M | HK$123M | HK$127M | HK$114M | HK$36.6M |
| Net income | HK$32.5M | -HK$14.1M | -HK$14.6M | -HK$29.2M | -HK$67.5M |
| Free cash flow | HK$214M | HK$179M | HK$140M | HK$71.4M | HK$81.0M |
| Capital expenditure | HK$62.4M | HK$41.1M | HK$50.4M | HK$59.5M | HK$42.3M |
| Total debt | n/a | HK$606M | HK$550M | HK$584M | HK$514M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 2609.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.7% | +2.1% | 2nd lowest of 20 |
| 6-month return | -58.1% | -3.4% | lowest of 19 |
| Distance from 52-week high | -68.0% | -18.4% | lowest of 21 |
| Revenue growth (TTM) | -1.9% | +11.9% | lowest of 21 |
| Operating margin | 4.7% | 10.7% | 4th lowest of 21 |
| EV / Sales | 2.4× | 2.6× | 10th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | 14.7% | 6.5% | 7th most demanding of 17 |
| Growth delivered (Del g) | +9.2% | +16.0% | 4th lowest of 17 |
| Hurdle (Req g minus delivered) | +5.6 pp | -7.1 pp | 4th most demanding of 17 |
| ROIC minus cost of capital | -3.0 pp | +1.1 pp | 7th lowest of 21 |
| EV / EBITDA | 17.8× | 12.9× | 8th most expensive of 18 |
| Net debt / EBITDA | -0.2× | 0.6× | 5th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Bayzed Health 2609.HK | Hong Kong | $375M | -58% | -2% | 5% | 2.4× | 14.7% | +9.2% |
| Bright Eye Hospital 301239.SZ | China | $377M | -26% | +11% | 9% | 1.3× | -5.1% | +15.5% |
| China Resources Medical 1515.HK | Hong Kong | $393M | -10% | 0% | 6% | 0.4× | -7.5% | +26.3% |
| Voxel VOX.WA | Poland | $393M | +59% | +14% | 24% | 2.7× | 1.2% | +12.2% |
| Indraprastha Medical INDRAMEDCO.NS | India | $351M | 0% | +11% | 15% | 1.9× | 14.9% | +19.3% |
| Charm Care 6062.T | Japan | $402M | +57% | +6% | 11% | 1.2× | -0.4% | +16.4% |
| KMC Speciality Hospitals (India) KMCSHIL.NS | India | $346M | n/a | +35% | 23% | 9.8× | 19.0% | +24.4% |
| Liaoning He Eye Hospital 301103.SZ | China | $342M | -20% | +3% | 4% | 0.9× | -4.2% | +5.4% |
| Viemed Healthcare VMD | United States | $333M | -9% | +22% | 8% | 1.1× | 6.8% | +15.5% |
| Q & M Dental Group (Singapore) QC7.SI | Singapore | $326M | -26% | +16% | 9% | 2.5× | 7.7% | +7.5% |
| Garofalo Health Care GHC.MI | Italy | $508M | -3% | +4% | 10% | 1.4× | 1.7% | +18.3% |
| Artemis Medicare Services ARTEMISMED.NS | India | $582M | +25% | +15% | 13% | 4.8× | 48.5% | +21.5% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | 4.1× | 17.4% | +18.1% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | 5.5× | 21.2% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 3.9× | n/a | n/a |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | 6.4× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | 0.9× | 6.1% | +6.0% |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 2.8× | 2.3% | +19.7% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 6.0× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 0.6× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 5.8× | 22.1% | +10.2% |